A local, provider-led program means your peptides come with baseline labs, dose adjustments based on follow-up data, and a care team you can actually reach
Semaglutide remains an excellent option for many with obesity or Type 2 diabetes, particularly when cost, availability, insurance coverage, or long-term affordability are important considerations, he adds
Federal plans including Canadian Armed Forces, Veterans Affairs Canada, and federal public service health plans have more consistent coverage for obesity medications, often matching or exceeding private sector coverage
Gallbladder Disease Semaglutide can also cause some gallbladder issues along with other gastrointestinal side effects
Comparatively, the top-selling drugs of recent years Humira and Keytruda each generated far less revenue in their first five years compared to these GLP-1 products